Key facts
- It has raised $105.0M; the latest was Later Stage VC ($64.9M) in Jan 2026.
- Notable investors include MassChallenge, General Catalyst, European Innovation Council, EIT Food, StartLife — 28 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 28 names
- ·Watchlist + deal alerts for Orbem
- ·The full record, as it builds
Funding rounds
No funding rounds for Orbem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orbem
Operator of an artificial intelligence-enabled imaging platform intended to generate non-invasive biological insights. The company offers magnetic resonance imaging combined with advanced data analysis, rapid nondestructive assessment, and large-scale biological data interpretation, enabling food producers, researchers, and biological innovators to reduce waste, improve quality and transparency, and support more sustainable and health-focused decision-making.
- Sector
- Information Technology
- HQ
- Munich, Germany
- Founded
- 2018
- Employees
- 170
- Website
- orbem.ai/
- Ownership
- Privately Held (backing)
Orbem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orbem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orbem in its N-PORT filings yet. We sweep new filings monthly.